These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37647426)

  • 1. Clinical and immunological characteristics for BK polyomavirus-associated nephropathy after kidney transplantation.
    Siripoon T; Apiwattanakul N; Mongkolrattanakul P; Tongsook C; Unwanatham N; Hongeng S; Kantachuvesiri S; Bruminhent J
    Immun Inflamm Dis; 2023 Aug; 11(8):e956. PubMed ID: 37647426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
    Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
    BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
    Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
    Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk factors associated with post-transplantation BKPyV nephropathy and BKPyV DNAemia: a prospective study in kidney transplant recipients.
    Lorant C; Zigmantaviciute J; Ali N; Bonnevier U; Tejde M; von Zur-Mühlen B; Eriksson BM; Bergqvist A; Westman G
    BMC Infect Dis; 2024 Feb; 24(1):245. PubMed ID: 38388351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BK and JC polyomavirus infections in Tunisian renal transplant recipients.
    Boukoum H; Nahdi I; Sahtout W; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
    J Med Virol; 2015 Oct; 87(10):1788-95. PubMed ID: 25952258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients.
    Imlay H; Whitaker K; Fisher CE; Limaye AP
    Transpl Infect Dis; 2018 Aug; 20(4):e12928. PubMed ID: 29809315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic CD4 T Cells Sustain Effective BK Polyomavirus-Specific CD8 T Cell Response in Kidney Transplant Recipients.
    Dekeyser M; de Goër de Herve MG; Hendel-Chavez H; Lhotte R; Scriabine I; Bargiel K; Boutin E; Herr F; Taupin JL; Taoufik Y; Durrbach A
    Kidney Int Rep; 2024 Aug; 9(8):2498-2513. PubMed ID: 39156165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Frequency US for BK Polyomavirus-associated Nephropathy after Kidney Transplant.
    Yang D; Zhuang B; Wang Y; Huang G; Xu M; Lin M; Wang W; Huang G; Wang C; Xie X; Xie X
    Radiology; 2022 Aug; 304(2):333-341. PubMed ID: 35503018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control study.
    Tanriver U; Emmerich F; Hummel JF; Jänigen B; Panning M; Arnold F; Tanriver Y
    Clin Transplant; 2022 Jul; 36(7):e14663. PubMed ID: 35368114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined detection of urine specific gravity and BK viruria on prediction of BK polyomavirus nephropathy in kidney transplant recipients.
    Chen XT; Wang ZY; Huang Y; Wang JY; Yang SC; Chen WF; Chen PS; Li J; Deng RH; Huang G
    Chin Med J (Engl); 2020 Jan; 133(1):33-40. PubMed ID: 31923102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China.
    Li P; Cheng D; Wen J; Ni X; Xie K; Li X; Chen J
    BMC Nephrol; 2021 Oct; 22(1):328. PubMed ID: 34600511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Incidence and Early Onset of Urinary Tract Cancers in Patients with BK Polyomavirus Associated Nephropathy.
    Li YJ; Wu HH; Chen CH; Wang HH; Chiang YJ; Hsu HH; Pang ST; Wang RYL; Tian YC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33799453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV infection, valganciclovir exposure, and the risk of BK viremia and associated nephropathy after kidney transplantation: Is there a link?
    Rodríguez-Goncer I; Ruiz-Ruigómez M; López-Medrano F; Corbella L; Polanco N; González Monte E; San Juan R; Ruiz-Merlo T; Parra P; Folgueira L; Andrés A; Aguado JM; Fernández-Ruiz M
    Transpl Infect Dis; 2021 Aug; 23(4):e13597. PubMed ID: 33751753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
    van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
    J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study.
    Keller N; Duquennoy S; Conrad A; Fafi-Kremer S; Morelon E; Bouvier N; Moulin B; Hurault De Ligny B; Caillard S
    Transpl Infect Dis; 2019 Apr; 21(2):e13058. PubMed ID: 30730102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.